Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti JP, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaüser M, Hale G, Verdonck L, Cairo M, Gupta V, Pavletic S; Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA. Ratanatharathorn V, et al. Among authors: pavletic s. Br J Haematol. 2009 Jun;145(6):816-24. doi: 10.1111/j.1365-2141.2009.07674.x. Epub 2009 Mar 26. Br J Haematol. 2009. PMID: 19344418 Free PMC article.
A survey of diagnosis, management, and grading of chronic GVHD.
Lee SJ, Vogelsang G, Gilman A, Weisdorf DJ, Pavletic S, Antin JH, Horowitz MM, Akpek G, Flowers ME, Couriel D, Martin PJ. Lee SJ, et al. Among authors: pavletic s. Biol Blood Marrow Transplant. 2002;8(1):32-9. doi: 10.1053/bbmt.2002.v8.pm11846354. Biol Blood Marrow Transplant. 2002. PMID: 11846354 Free article.
Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation.
Bishop MR, Steinberg SM, Gress RE, Hardy NM, Marchigiani D, Kasten-Sportes C, Dean R, Pavletic SZ, Gea-Banacloche J, Castro K, Hakim F, Krumlauf M, Read EJ, Carter C, Leitman SF, Fowler DH. Bishop MR, et al. Br J Haematol. 2004 Sep;126(6):837-43. doi: 10.1111/j.1365-2141.2004.05133.x. Br J Haematol. 2004. PMID: 15352988 Free article. Clinical Trial.
Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
Pavletic SZ, Khouri IF, Haagenson M, King RJ, Bierman PJ, Bishop MR, Carston M, Giralt S, Molina A, Copelan EA, Ringdén O, Roy V, Ballen K, Adkins DR, McCarthy P, Weisdorf D, Montserrat E, Anasetti C. Pavletic SZ, et al. J Clin Oncol. 2005 Aug 20;23(24):5788-94. doi: 10.1200/JCO.2005.03.962. Epub 2005 Jul 25. J Clin Oncol. 2005. PMID: 16043827
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, Shaughnessy P, Hymes S, Kim S, Wayne AS, Chien JW, Neumann J, Mitchell S, Syrjala K, Moravec CK, Abramovitz L, Liebermann J, Berger A, Gerber L, Schubert M, Filipovich AH, Weisdorf D, Schubert MM, Shulman H, Schultz K, Mittelman B, Pavletic S, Vogelsang GB, Martin PJ, Lee SJ, Flowers ME. Couriel D, et al. Among authors: pavletic s. Biol Blood Marrow Transplant. 2006 Apr;12(4):375-96. doi: 10.1016/j.bbmt.2006.02.003. Biol Blood Marrow Transplant. 2006. PMID: 16545722 Free article.
Chronic graft versus host disease.
Baird K, Pavletic SZ. Baird K, et al. Curr Opin Hematol. 2006 Nov;13(6):426-35. doi: 10.1097/01.moh.0000245689.47333.ff. Curr Opin Hematol. 2006. PMID: 17053454 Review.
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease.
Macmillan ML, Couriel D, Weisdorf DJ, Schwab G, Havrilla N, Fleming TR, Huang S, Roskos L, Slavin S, Shadduck RK, Dipersio J, Territo M, Pavletic S, Linker C, Heslop HE, Deeg HJ, Blazar BR. Macmillan ML, et al. Among authors: pavletic s. Blood. 2007 Mar 15;109(6):2657-62. doi: 10.1182/blood-2006-08-013995. Epub 2006 Nov 16. Blood. 2007. PMID: 17110457 Free article. Clinical Trial.
Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.
Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D. Giralt S, et al. Among authors: pavletic s. Biol Blood Marrow Transplant. 2007 Jul;13(7):844-52. doi: 10.1016/j.bbmt.2007.03.011. Epub 2007 May 24. Biol Blood Marrow Transplant. 2007. PMID: 17580263 Free article.
316 results